태아 모니터링 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of fetal monitoring Market

The global fetal monitoring market was valued at USD 3.28 billion in 2025 and is projected to grow from USD 3.46 billion in 2026 to USD 5.45 billion by 2034, registering a CAGR of 5.83% during 2026-2034. North America dominated the global market with a 34.48% share in 2025, supported by advanced obstetric care infrastructure and strong regulatory oversight.

Fetal monitoring devices are used to evaluate fetal heart rate, uterine contractions, fetal movement, and overall fetal well-being during pregnancy and labor. These systems are critical in identifying fetal distress, guiding obstetric intervention, and minimizing adverse birth outcomes. Rising maternal age, increasing high-risk pregnancies, growing cesarean section rates, and demand for real-time labor monitoring are key contributors to market expansion. Additionally, adoption of portable, wireless, and non-invasive monitoring solutions is strengthening growth prospects.

Market Dynamics

Market Drivers

Rising Rate of High-Risk Pregnancies to Support Market Growth

An increasing number of pregnancies are categorized as high-risk due to maternal age, gestational diabetes, hypertension, preeclampsia, and assisted reproductive technologies such as IVF. High-risk cases require frequent and often continuous fetal heart rate monitoring to detect complications early. According to the Cleveland Clinic, approximately 6-8% of pregnancies in the U.S. are high-risk annually.

Hospitals are standardizing cardiotocography (CTG) during labor to enable timely intervention and reduce neonatal morbidity. This clinical necessity is driving demand for CTG monitors, telemetry systems, and advanced fetal transducers.

Market Restraints

Regulatory and Accuracy Concerns in Non-Invasive Continuous Monitoring

Although wearable and non-invasive fetal monitors are gaining popularity, they face regulatory scrutiny regarding signal accuracy and differentiation between maternal and fetal heart rates. False alarms may lead to unnecessary interventions such as emergency C-sections. Additionally, high costs of advanced CTG and wireless telemetry systems limit adoption in smaller maternity centers and low-income regions.

Market Opportunities

Integration of AI and Decision-Support Analytics

AI-based fetal monitoring platforms that interpret heart rate variability and contraction patterns present strong growth opportunities. These solutions reduce inter-clinician variability and improve early detection of fetal distress. Cloud-based connectivity enables remote obstetric review and real-time alerts. Vendors offering integrated hardware, wireless patches, and AI-powered analytics are well-positioned to secure higher-value hospital contracts.

Market Challenges

False Alarms and Clinical Liability

Continuous CTG monitoring often generates "non-reassuring" tracings that are not clinically significant. This may increase defensive decision-making and raise C-section rates. Hospitals must balance safety with unnecessary intervention. Signal dropouts in patients with higher BMI or during movement also pose operational challenges.

Market Trends

Shift Toward Non-Invasive and Wireless Monitoring

A major trend is the shift from traditional belt-based monitors to wireless and patch-based systems that enhance maternal mobility during labor. Wireless telemetry allows patients to ambulate freely while maintaining continuous monitoring.

For instance, in February 2024, GE HealthCare received U.S. FDA 510(k) clearance for its Novii+ Wireless Maternal and Fetal Monitoring Solution, designed to support mobility during antepartum and intrapartum monitoring.

Segmentation Analysis

By Method

The market is segmented into invasive and non-invasive methods.

• The non-invasive segment dominated in 2024 and is projected to account for 67.77% of the market in 2026, due to safety and reduced infection risk.
• The invasive segment is expected to grow at a CAGR of 4.6% through 2034.

By Product

Segments include instruments and consumables.

• The consumables segment led the market with 62.3% share in 2025 and is projected to account for 64.84% in 2026, driven by high replacement frequency.
• Instruments are projected to grow at a CAGR of 5.1%.

By Application

The market includes antepartum and intrapartum monitoring.

• Intrapartum monitoring dominated with 54.3% share in 2025 and is expected to hold 53.99% in 2026, due to continuous monitoring during labor.
• Antepartum monitoring is expected to grow at a CAGR of 6.3%.

By End User

Hospitals, home care settings, diagnostic centers, and others comprise the segment.

• Hospitals dominated and are projected to account for 75.76% of the market in 2026.
• Home care settings are expected to grow at a CAGR of 6.6%.

Regional Outlook

North America

North America generated USD 1.13 billion in 2025 and USD 1.19 billion in 2026, maintaining leadership due to strong adoption of advanced fetal monitoring technologies.

Europe

Europe is projected to reach USD 0.95 billion in 2026, supported by strong pre-birth care standards and infection prevention protocols.

Asia Pacific

Asia Pacific is expected to grow at the fastest CAGR, reaching USD 1.05 billion in 2026, driven by rising healthcare investments in China and India.

Latin America and Middle East & Africa

These regions are projected to witness moderate growth due to improving healthcare infrastructure and increasing maternal health awareness.

Competitive Landscape

The market is moderately consolidated with leading players such as Philips Healthcare, GE HealthCare, Mindray Medical, Huntleigh Healthcare (Arjo), and Monica Healthcare. Companies emphasize clinical accuracy, wireless connectivity, AI-assisted interpretation, and patient comfort to strengthen market position. Strategic partnerships, FDA approvals, and expansion into remote monitoring solutions remain key competitive strategies.

Conclusion

The global fetal monitoring market is projected to grow from USD 3.28 billion in 2025 to USD 5.45 billion by 2034, expanding at a CAGR of 5.83%. Rising high-risk pregnancies, technological advancements in wireless and AI-enabled monitoring, and increasing emphasis on safe childbirth practices are key growth drivers. While regulatory scrutiny and false alarm challenges persist, innovation in non-invasive, connected, and decision-support systems is expected to sustain long-term market expansion through 2034.

Segmentation By Method

• Invasive
• Non-Invasive

By Product

• Consumables
  • Electrodes
  • Ultrasound Gel & Couplants
  • Disposable Sensors
  • Others
• Instrument
  • Ultrasound Fetal Monitors
  • Electronic Fetal Monitors (EFM)
  • Fetal Dopplers
  • Others

By Application

• Antepartum Monitoring
• Intrapartum Monitoring

By End-User

• Hospitals
• Home Care Settings
• Diagnostic & Imaging Centers
• Others

By Region

• North America (By Method, Product, Application, End-User, and Country)
  • U.S.
    • By Product
  • Canada
    • By Product
• Europe (By Method, Product, Application, End-User, and Country/Sub-region)
  • Germany
    • By Product
  • U.K.
    • By Product
  • France
    • By Product
  • Spain
    • By Product
  • Italy
    • By Product
  • Scandinavia
    • By Product
  • Rest of Europe
    • By Product
• Asia Pacific (By Method, Product, Application, End-User, and Country/Sub-region)
  • China
    • By Product
  • Japan
    • By Product
  • India
    • By Product
  • Australia
    • By Product
  • Southeast Asia
    • By Product
  • Rest of Asia Pacific
    • By Product
• Latin America (By Method, Product, Application, End-User, and Country/Sub-region)
  • Brazil
    • By Product
  • Mexico
    • By Product
  • Rest of Latin America
    • By Product
• Middle East & Africa (By Method, Product, Application, End-User, and Country/Sub-region)
  • GCC
    • By Product
  • South Africa
    • By Product
  • Rest of Middle East & Africa
    • By Product

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2024/2025
• 4.2. Technological Advancements in Fetal Monitoring
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Method
  • 5.1.1. Invasive
  • 5.1.2. Non-Invasive
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Consumables
    • 5.2.1.1. Electrodes
    • 5.2.1.2. Ultrasound Gel & Couplants
    • 5.2.1.3. Disposable Sensors
    • 5.2.1.4. Others
  • 5.2.2. Instrument
    • 5.2.2.1. Ultrasound Fetal Monitors
    • 5.2.2.2. Electronic Fetal Monitors (EFM)
    • 5.2.2.3. Fetal Dopplers
    • 5.2.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Antepartum Monitoring
  • 5.3.2. Intrapartum Monitoring
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals
  • 5.4.2. Home Care Settings
  • 5.4.3. Diagnostic & Imaging Centers
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Method
  • 6.1.1. Invasive
  • 6.1.2. Non-Invasive
• 6.2. Market Analysis, Insights and Forecast - By Product
  • 6.2.1. Consumables
    • 6.2.1.1. Electrodes
    • 6.2.1.2. Ultrasound Gel & Couplants
    • 6.2.1.3. Disposable Sensors
    • 6.2.1.4. Others
  • 6.2.2. Instrument
    • 6.2.2.1. Ultrasound Fetal Monitors
    • 6.2.2.2. Electronic Fetal Monitors (EFM)
    • 6.2.2.3. Fetal Dopplers
    • 6.2.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Antepartum Monitoring
  • 6.3.2. Intrapartum Monitoring
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals
  • 6.4.2. Home Care Settings
  • 6.4.3. Diagnostic & Imaging Centers
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Method
  • 6.5.2. Canada
    • 6.5.2.1. By Method

7. Europe Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Method
  • 7.1.1. Invasive
  • 7.1.2. Non-Invasive
• 7.2. Market Analysis, Insights and Forecast - By Product
  • 7.2.1. Consumables
    • 7.2.1.1. Electrodes
    • 7.2.1.2. Ultrasound Gel & Couplants
    • 7.2.1.3. Disposable Sensors
    • 7.2.1.4. Others
  • 7.2.2. Instrument
    • 7.2.2.1. Ultrasound Fetal Monitors
    • 7.2.2.2. Electronic Fetal Monitors (EFM)
    • 7.2.2.3. Fetal Dopplers
    • 7.2.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Antepartum Monitoring
  • 7.3.2. Intrapartum Monitoring
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals
  • 7.4.2. Home Care Settings
  • 7.4.3. Diagnostic & Imaging Centers
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Method
  • 7.5.2. Germany
    • 7.5.2.1. By Method
  • 7.5.3. France
    • 7.5.3.1. By Method
  • 7.5.4. Spain
    • 7.5.4.1. By Method
  • 7.5.5. Italy
    • 7.5.5.1. By Method
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Method
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Method

8. Asia Pacific Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Method
  • 8.1.1. Invasive
  • 8.1.2. Non-Invasive
• 8.2. Market Analysis, Insights and Forecast - By Product
  • 8.2.1. Consumables
    • 8.2.1.1. Electrodes
    • 8.2.1.2. Ultrasound Gel & Couplants
    • 8.2.1.3. Disposable Sensors
    • 8.2.1.4. Others
  • 8.2.2. Instrument
    • 8.2.2.1. Ultrasound Fetal Monitors
    • 8.2.2.2. Electronic Fetal Monitors (EFM)
    • 8.2.2.3. Fetal Dopplers
    • 8.2.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Antepartum Monitoring
  • 8.3.2. Intrapartum Monitoring
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals
  • 8.4.2. Home Care Settings
  • 8.4.3. Diagnostic & Imaging Centers
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Method
  • 8.5.2. Australia
    • 8.5.2.1. By Method
  • 8.5.3. China
    • 8.5.3.1. By Method
  • 8.5.4. India
    • 8.5.4.1. By Method
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Method
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Method

9. Latin America Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Method
  • 9.1.1. Invasive
  • 9.1.2. Non-Invasive
• 9.2. Market Analysis, Insights and Forecast - By Product
  • 9.2.1. Consumables
    • 9.2.1.1. Electrodes
    • 9.2.1.2. Ultrasound Gel & Couplants
    • 9.2.1.3. Disposable Sensors
    • 9.2.1.4. Others
  • 9.2.2. Instrument
    • 9.2.2.1. Ultrasound Fetal Monitors
    • 9.2.2.2. Electronic Fetal Monitors (EFM)
    • 9.2.2.3. Fetal Dopplers
    • 9.2.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Antepartum Monitoring
  • 9.3.2. Intrapartum Monitoring
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals
  • 9.4.2. Home Care Settings
  • 9.4.3. Diagnostic & Imaging Centers
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Method
  • 9.5.2. Mexico
    • 9.5.2.1. By Method
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Method

10. Middle East &Africa Fetal Monitoring Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Method
  • 10.1.1. Invasive
  • 10.1.2. Non-Invasive
• 10.2. Market Analysis, Insights and Forecast - By Product
  • 10.2.1. Consumables
    • 10.2.1.1. Electrodes
    • 10.2.1.2. Ultrasound Gel & Couplants
    • 10.2.1.3. Disposable Sensors
    • 10.2.1.4. Others
  • 10.2.2. Instrument
    • 10.2.2.1. Ultrasound Fetal Monitors
    • 10.2.2.2. Electronic Fetal Monitors (EFM)
    • 10.2.2.3. Fetal Dopplers
    • 10.2.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Antepartum Monitoring
  • 10.3.2. Intrapartum Monitoring
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals
  • 10.4.2. Home Care Settings
  • 10.4.3. Diagnostic & Imaging Centers
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Method
  • 10.5.2. GCC
    • 10.5.2.1. By Method
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Method

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.2.1. GE HealthCare Technologies Inc.
  • 11.2.2. Koninklijke Philips N.V.
  • 11.2.3. Mindray Medical International Ltd.
  • 11.2.4. Nihon Kohden Corporation
  • 11.2.5. Analogic Corporation
  • 11.2.6. Huntleigh Healthcare Limited
  • 11.2.7. Bionet Co., Ltd.
  • 11.2.8. Edan Instruments, Inc.
  • 11.2.9. Spacelabs Healthcare
  • 11.2.10. Dragerwerk AG & Co. KGaA